We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.91B
AUM Growth
-$33.5M
Cap. Flow
-$96.8M
Cap. Flow %
-1.4%
Top 10 Hldgs %
55.6%
Holding
295
New
67
Increased
47
Reduced
98
Closed
74

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$81.6M
2
NVRO
NEVRO CORP.
NVRO
+$68M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$61.4M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$55.5M
5
KDP icon
Keurig Dr Pepper
KDP
+$44.2M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$105M
2
OGN icon
Organon & Co
OGN
+$75.3M
3
EXAS
Exact Sciences
EXAS
+$69M
4
BIIB icon
Biogen
BIIB
+$57.7M
5
CENTA icon
Central Garden & Pet Co Class A
CENTA
+$53.3M

Sector Composition

Rank Sector Weight
1 Healthcare 39.29%
2 Consumer Staples 5.94%
3 Technology 4.58%
4 Consumer Discretionary 4.41%
5 Communication Services 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNVS icon
151
Cineverse
CNVS
$58.5M
$1.75M 0.03%
+919,333
New +$5.5M
XPOF icon
152
Xponential Fitness
XPOF
$278M
$1.73M 0.03%
+100,000
New +$2.83M
ATHX
153
DELISTED
Athersys, Inc. Common Stock
ATHX
$1.69M 0.02%
+1,943,000
New +$1.75M
VAPO
154
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$1.68M 0.02%
471,250
-97,592
-17% -$448K
SKIN icon
155
SkinHealth Systems
SKIN
$90.6M
$1.67M 0.02%
+200,000
New +$2.08M
PRSO icon
156
Peraso
PRSO
$10.8M
$1.19M 0.02%
60,025
+48,775
+434% +$983K
AUMN
157
DELISTED
Golden Minerals Company
AUMN
$1.11M 0.02%
+686,413
New +$2.92M
REAL icon
158
The RealReal
REAL
$1.51B
$1.11M 0.02%
+500,000
New +$684K
SBFM
159
Sunshine Biopharma
SBFM
$2.78M
$1.08M 0.02%
+110
New +$1.33M
MBOT icon
160
Microbot Medical
MBOT
$119M
$1.05M 0.02%
385,246
-214,754
-36% -$430K
BCTXW
161
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$938K 0.01%
375,000
-1
-0% -$3
EZRA
162
Reliance Global Group
EZRA
$2.18M
$730K 0.01%
228
– –
STKH
163
Steakholder Foods
STKH
$1.64M
$677K 0.01%
671
+349
+108% +$324K
DRCTW
164
DELISTED
Direct Digital Holdings, Inc. Warrant
DRCTW
$612K 0.01%
900,000
-1
-0% -$1
ASNS
165
DELISTED
ACTELIS NETWORKS INC
ASNS
$589K 0.01%
+18,533
New +$598K
OPGN
166
DELISTED
OpGen, Inc
OPGN
$510K 0.01%
+62,618
New +$511K
YTEN
167
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$480K 0.01%
+9,000
New +$586K
APCXW
168
DELISTED
AppTech Payments Corp Warrant
APCXW
$415K 0.01%
715,000
-1
-0% –
SPCB icon
169
SuperCom
SPCB
$68.1M
$362K 0.01%
18,188
-5,181
-22% -$120K
AGRX
170
DELISTED
Agile Therapeutics
AGRX
$360K 0.01%
+122,000
New +$649K
NBSE
171
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$311K ﹤0.01%
+166,174
New +$547K
HCDI
172
DELISTED
Harbor Custom Development, Inc. Common Stock
HCDI
$296K ﹤0.01%
+98,000
New +$422K
TCBP
173
DELISTED
TC BioPharm (Holdings) plc American Depositary Shares
TCBP
$286K ﹤0.01%
165
+127
+334% +$408K
NXGLW icon
174
NexGel Inc Warrant
NXGLW
$238K ﹤0.01%
550,000
-1
-0% –
YYAI icon
175
AiRWA Inc
YYAI
$126K
$225K ﹤0.01%
1
– –
5 6
7
8 9

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Armistice Capital held 295 positions worth $6.91B, down 0.48% from $6.94B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital's Q2 2023 filing shows 67 new, 47 increased, 98 reduced and 74 closed positions. Its largest new stake was Pfizer: 2,096,000 shares worth $76.9M. The largest sale was GSK, an estimated $105M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 44% a quarter earlier, followed by Consumer Staples and Technology.

  • Armistice Capital's largest Q2 2023 buy was Pfizer: 2,096,000 shares worth $76.9M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2023, an estimated $55.5M increase.
  • Armistice Capital's biggest Q2 2023 reduction was GSK, cutting an estimated $105M.
  • Armistice Capital fully exited Organon & Co in Q2 2023, selling an estimated $75.3M.
  • Armistice Capital's ten largest holdings make up 56% of its $6.91B portfolio in Q2 2023.
  • Armistice Capital opened 67 new positions and closed 74 in Q2 2023.
  • Armistice Capital's portfolio value fell 0.48% quarter-over-quarter to $6.91B.

Based on Armistice Capital's 13F filing for Q2 2023, filed 14 Aug 2023.